MARKET

NMS

NMS

Nuveen MN Quality Muni Inc
NYSE
10.85
-0.01
-0.05%
Closed 15:33 04/24 EDT
OPEN
10.85
PREV CLOSE
10.85
HIGH
10.85
LOW
10.82
VOLUME
18.61K
TURNOVER
0
52 WEEK HIGH
11.67
52 WEEK LOW
8.99
TOTAL ASSET
72.63M
YTD YIELD
2.11%
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at NMS last week (0415-0419)?
Weekly Report · 2d ago
Intra-Cellular Therapies gains on meeting main goal in trial for its depression treatment
Intra-Cellular Therapies gains on meeting main goal in trial for its depression treatment. The company's shares rise about 20% premarket. Lumateperone 42 mg met primary and secondary goals in late-stage study for treatment of major depressive disorder.
Seeking Alpha · 04/16 13:01
Weekly Report: what happened at NMS last week (0408-0412)?
Weekly Report · 04/15 10:04
Weekly Report: what happened at NMS last week (0401-0405)?
Weekly Report · 04/08 10:07
Weekly Report: what happened at NMS last week (0325-0329)?
Weekly Report · 04/01 10:06
Weekly Report: what happened at NMS last week (0318-0322)?
Weekly Report · 03/25 10:08
Weekly Report: what happened at NMS last week (0311-0315)?
Weekly Report · 03/18 10:07
Weekly Report: what happened at NMS last week (0304-0308)?
Weekly Report · 03/11 10:05
More
Profile
Fund Name
Nuveen MN Quality Muni Inc
Inception Date
1993-06-25
Benchmark
S&P Municipal Bond Minnesota TR
Advisor Company
Nuveen Fund Advisors LLC
Custodian
State Street Bank and Trust Co
Manager
Stephen Candido, Christopher Drahn, Michael Hamilton